<DOC>
	<DOCNO>NCT00717938</DOCNO>
	<brief_summary>The endpoint investigate addition low molecular heparin - enoxaparin , result significant increase overall survival patient small cell lung cancer , receive standard chemotherapy .</brief_summary>
	<brief_title>A Study Standard Treatment +/- Enoxaparin Small Cell Lung Cancer</brief_title>
	<detailed_description>Chemotherapy give accordance local regional guideline shall include platinum drug + topoisomerase inhibitor . Within limit study accept different local variant long centre remain consistent declared standard chemotherapy regimen . The recommended regimen carboplatin cisplatin plus etoposide q3 week 4 cycle 6 cycle allow . Local dosage dose reduction schedule use .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Topoisomerase Inhibitors</mesh_term>
	<criteria>1 . Histologically cytologically verify SCLC , stag 2. WHO performance status 0 , 1 , 2 3 3 . Age 18 year old 4 . Intention feasibility treat chemotherapy consist platinum + topoisomerase inhibitor . 5 . Platelets &gt; 100 x109 /L 6 . Signed informed consent 7 . PK ( prothrombin complex ) INR APTT within normal range . 1 . Prior systemic chemotherapy lung cancer . 2 . Concomitant anticoagulation treatment , except ASA clopidogrel 3 . Active overt bleed clinical importance high risk ( e.g . early observed haemorrhage brain metastasis , severe coagulopathy haemophilia , severe liver dysfunction impaired coagulation , acute peptic ulcer , within last 3 month suffer intracranial haemorrhage , surgery central nervous system ) . 4 . Any known contraindication enoxaparine ( e.g . Hypersensitivity enoxaparine derivative ) . 5 . Pregnancy breastfeed 6 . Fertile woman use effective contraceptive men agree use effective contraception treatment period . 7 . Treatment investigational agent , participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>